Bill
A 3852
Establishes Psilocybin behavioral Health Access and Therapy Pilot Program; appropriates $6 million.*
2024-2025 Regular Session
Introduced by Clinton Calabrese and 4 co-sponsors
New Jersey funds $6M pilot program to study psilocybin's therapeutic use for behavioral health under controlled medical supervision, advancing research into Schedule I substance treatment.
Reported out of Senate Committee with Amendments and Referred to Assembly Appropriations Committee